RecruitingPhase 3ACTRN12605000017628
Effect of Vitamin D Supplementation on Blood Pressure and Insulin Sensitivity
A randomised phase III study to evaluate the effects of Vitamin D supplementation on patients with low vitamin D levels to reduce blood pressure levels and improve insulin sensitivity
Sponsor
University of Auckland
Enrollment
120 participants
Start Date
Jul 7, 2005
Study Type
Interventional
Conditions
Eligibility
Sex: Both males and femalesMin Age: 40 Yearss
Inclusion Criteria1
- Aged >40 years (Tongan and Maori) and >65 years (European) 25OHD levels <50 nmol/L.
Exclusion Criteria1
- Treated diabetes, treated hypertension, taking of vitamin D supplements (including cod liver oil); serum calcium level above 2.60 mmol/L, regular outdoor activities during the middle of day during the study period, recent high sun exposure (eg. holidays in the Pacific islands); or planned holidays to areas with high sun exposure during the study period.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
A randomised double-blind clinical trial of 100 ug daily doses of vitamin D3 versus placebo tablets.
A randomised double-blind clinical trial of 100 ug daily doses of vitamin D3 versus placebo tablets.
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12605000017628
Related Trials
Multidimensional Sleep Health Intervention for Couples
NCT076032451 location
Effectiveness and Adoption of the TelTex4BP Intervention Among Adults With Hypertension in Nepal
NCT059791682 locations
Community-based Implementation of Adapted STAC
NCT066899301 location
Non-Invasive Blood Pressure Accuracy Study for Adult Subjects
NCT076282961 location
The Continuity Study
NCT072165731 location